Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-25-058357
Filing Date
2025-04-25
Accepted
2025-04-25 08:34:11
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-25

Document Format Files

Seq Description Document Type Size
1 ARS 2025_ars_-_proxy.pdf ARS 15440353
  Complete submission text file 0000950170-25-058357.txt   21259900
Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Filer) CIK: 0001781174 (see all company filings)

EIN.: 825125532 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-41551 | Film No.: 25870128
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)